Koers Shanghai Shyndec Pharmaceutical Co., Ltd.
Aandelen
600420
CNE000001JG2
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
10,61 CNY | -0,66% | +1,14% | +8,38% |
Omzet 2024 * | 13,35 mld. 1,84 mld. 1,72 mld. | Omzet 2025 * | 14,69 mld. 2,03 mld. 1,9 mld. | Marktkapitalisatie | 14,23 mld. 1,96 mld. 1,84 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 863 mln. 119 mln. 111 mln. | Nettowinst (verlies) 2025 * | 996 mln. 137 mln. 129 mln. | EV/omzet 2024 * | 1,07 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 0,97 x |
K/w-verhouding 2024 * |
16,6
x | K/w-verhouding 2025 * |
14,3
x | Werknemers | 11.608 |
Dividendrendement 2024 * |
14,1% | Dividendrendement 2025 * |
17% | Vrij verhandelbaar | 39,64% |
1 dag | -0,66% | ||
1 week | +1,14% | ||
Lopende maand | +18,68% | ||
1 maand | +20,43% | ||
3 maanden | +16,34% | ||
6 maanden | +8,71% | ||
Lopend jaar | +8,38% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Wan Yong Lian
PSD | President | 54 | 24-09-22 |
Hao Li
DFI | Director of Finance/CFO | 59 | 18-11-16 |
Qian Yin Jing
IRC | Investor Relations Contact | 44 | 13-09-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Yong Gang Xing
CHM | Chairman | 48 | 25-11-19 |
Yong Liu
BRD | Director/Board Member | 55 | 17-05-21 |
Shu Yuan Wei
BRD | Director/Board Member | 60 | 29-05-20 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +2,14% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
26-04-24 | 10,61 | -0,66% | 24 159 470 |
25-04-24 | 10,68 | +2,69% | 32 644 090 |
24-04-24 | 10,4 | +0,39% | 26 739 850 |
23-04-24 | 10,36 | -1,52% | 24 845 240 |
22-04-24 | 10,52 | +0,29% | 33 565 740 |
slotkoers Shanghai S.E., 26 april 2024
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+8,38% | 1,96 mld. | |
+5,31% | 70,44 mld. | |
+10,97% | 8,94 mld. | |
-16,83% | 4,75 mld. | |
+43,48% | 4,5 mld. | |
+3,20% | 3,85 mld. | |
+18,82% | 2,38 mld. | |
-21,36% | 2,34 mld. | |
-29,67% | 2,2 mld. | |
-0,50% | 1,64 mld. |